Synonyms: Rob-803 | Rob803
Compound class:
Synthetic organic
Comment: Rabeximod is an orally active immunomodulator. It has potent anti-rheumatic effects in animal models and is being evaluated as a potential drug for rheumatoid arthritis patients. The structure was originally claimed in patent WO2005123741A1 (Compound E) for anti-inflammatory potential [1], and later for antiviral potential in patent WO2014140321A1 (example 2). The molecular mechanism of action of this compound vis its anti-inflammatory activity remains unclear.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
2-(9-chloro-2,3-dimethylindolo[3,2-b]quinoxalin-6-yl)-N-[2-(dimethylamino)ethyl]acetamide |
International Nonproprietary Names | |
INN number | INN |
8866 | rabeximod |
Synonyms |
Rob-803 | Rob803 |
Database Links | |
CAS Registry No. | 872178-65-9 (source: WHO INN record) |
DrugBank Ligand | DB05772 |
GtoPdb PubChem SID | 363894150 |
PubChem CID | 56841552 |
Search Google for chemical match using the InChIKey | PDNNUMNEXITLCZ-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | PDNNUMNEXITLCZ |
Search PubMed clinical trials | rabeximod |
Search PubMed titles | rabeximod |
Search PubMed titles/abstracts | rabeximod |
UniChem Compound Search for chemical match using the InChIKey | PDNNUMNEXITLCZ-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | PDNNUMNEXITLCZ-UHFFFAOYSA-N |